Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-18-000890
Filing Date
2018-02-12
Accepted
2018-02-12 16:22:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 FENNEC PHARMACEUTICALS INC. p18-0266sc13g.htm SC 13G 62600
  Complete submission text file 0000902664-18-000890.txt   64387
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Subject) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80470 | Film No.: 18596626
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036
Business Address 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036 212-937-4975
venBio Select Advisor LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G